Search

Search Constraints

You searched for: Author/Creator Nakagawa, Hidewaki

Search Results

1. Association between germline pathogenic variants in cancer‐predisposing genes and lymphoma risk. Issue 11 (5th September 2022)

2. Bile acid dysmetabolism in the gut‐microbiota‐liver axis under hepatitis C virus infection. (5th September 2021)

3. Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinoma. Issue 2 (25th January 2019)

4. Clinical Utility of Germline Genetic Testing in Japanese Men Undergoing Prostate Biopsy. Issue 1 (9th January 2022)

5. Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy. Issue 2 (22nd October 2020)

6. Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy. Issue 2 (22nd October 2020)

7. Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy. Issue 2 (22nd October 2020)

8. Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy. Issue 2 (22nd October 2020)

9. Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy. Issue 2 (22nd October 2020)

10. Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy. Issue 2 (22nd October 2020)